Safety of non‑peptide thrombopoietin receptor agonists in patients with immune thrombocytopenia: A systematic review and meta‑analysis of short‑term double‑blind randomized clinical trials

The aim of the present study was to analyze the safety of non-peptide thrombopoietin receptor agonists (TPO-RAs) for immune thrombocytopenia (ITP) treatment. All studies reporting adverse events (AEs) in relation to ITP treatment with eltrombopag, avatrombopag, and hetrombopag were retrieved from Pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Nan, Qiao, Jibing, Jiang, Yazhou, Yin, Hanjun, Li, Min, Zhu, Suyue, Li, Jianqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347292/
https://www.ncbi.nlm.nih.gov/pubmed/37456173
http://dx.doi.org/10.3892/etm.2023.12092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347292/
https://www.ncbi.nlm.nih.gov/pubmed/37456173
http://dx.doi.org/10.3892/etm.2023.12092

Ejemplares similares